Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Neuroimmunomodulation ; 25(3): 163-175, 2018.
Article in English | MEDLINE | ID: mdl-30415249

ABSTRACT

OBJECTIVES: Gastrointestinal (GI) inflammation and GI integrity deficits are common comorbidities of neuropsychiatric disorders. Ongoing research suggests that these aberrations may be contributing to heightened immune signals that have the potential to disrupt neuronal homeostasis and exacerbate behavioural deficits. The current study aimed to determine whether the well-characterized animal model of neuropsychopathology, the maternal immune activation (MIA) model, produced GI inflammation and integrity disruptions in association with anxiety-like behaviour. METHODS: Pregnant Wistar rats were exposed to the viral mimetic polyriboinosinic:polyribocytidilic acid (polyI:C) on gestational days (GD) 10 and 19. Evidence of ANS activation, GI inflammation, and GI barrier integrity was assessed in both neonatal (postnatal day, P7) and adult (P84) offspring. Anxiety-like behaviour was assessed at P100. RESULTS: Neonatal MIA offspring exhibited an altered intestinal inflammatory profile and evidence of an increase in lymphoid aggregates. MIA neonates also displayed disruptions to GI barrier tight junction protein mRNA. In addition, adult MIA offspring exhibited an increase in anxiety-like behaviours. CONCLUSION: These results indicate that the MIA rat model, which is well documented to produce behavioural, neurochemical, and neuroanatomical abnormalities, also produces GI inflammation and integrity disruptions. We suggest that this model may be a useful tool to elucidate biological pathways associated with neuropsychiatric disorders.


Subject(s)
Anxiety/chemically induced , Anxiety/immunology , Gastrointestinal Tract/immunology , Inflammation Mediators/immunology , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/immunology , Animals , Anxiety/metabolism , Disease Models, Animal , Female , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/metabolism , Inflammation/chemically induced , Inflammation/immunology , Inflammation/metabolism , Inflammation Mediators/metabolism , Male , Maze Learning/physiology , Poly I-C/toxicity , Pregnancy , Prenatal Exposure Delayed Effects/metabolism , Rats , Rats, Wistar
2.
Brain Behav Immun ; 56: 187-96, 2016 Aug.
Article in English | MEDLINE | ID: mdl-26923065

ABSTRACT

Maternal immune activation (MIA) and adolescent cannabinoid exposure (ACE) have both been identified as major environmental risk factors for schizophrenia. We examined the effects of these two risk factors alone, and in combination, on gene expression during late adolescence. Pregnant rats were exposed to the viral infection mimic polyriboinosinic-polyribocytidylic acid (poly I:C) on gestational day (GD) 15. Adolescent offspring received daily injections of the cannabinoid HU210 for 14days starting on postnatal day (PND) 35. Gene expression was examined in the left entorhinal cortex (EC) using mRNA microarrays. We found prenatal treatment with poly I:C alone, or HU210 alone, produced relatively minor changes in gene expression. However, following combined treatments, offspring displayed significant changes in transcription. This dramatic and persistent alteration of transcriptional networks enriched with genes involved in neurotransmission, cellular signalling and schizophrenia, was associated with a corresponding perturbation in the expression of small non-coding microRNA (miRNA). These results suggest that a combination of environmental exposures during development leads to significant genomic remodeling that disrupts maturation of the EC and its associated circuitry with important implications as the potential antecedents of memory and learning deficits in schizophrenia and other neuropsychiatric disorders.


Subject(s)
Cannabinoid Receptor Agonists/pharmacology , Entorhinal Cortex , Gene Expression , Gene Regulatory Networks , Poly I-C , Prenatal Exposure Delayed Effects , Virus Diseases , Age Factors , Animals , Cannabinoid Receptor Agonists/administration & dosage , Disease Models, Animal , Dronabinol/administration & dosage , Dronabinol/analogs & derivatives , Dronabinol/pharmacology , Entorhinal Cortex/drug effects , Entorhinal Cortex/immunology , Entorhinal Cortex/metabolism , Female , Gene Expression/drug effects , Gene Expression/genetics , Gene Expression/immunology , Gene Regulatory Networks/drug effects , Gene Regulatory Networks/genetics , Gene Regulatory Networks/immunology , Poly I-C/administration & dosage , Pregnancy , Prenatal Exposure Delayed Effects/immunology , Rats , Rats, Wistar , Virus Diseases/immunology
3.
BMC Genomics ; 15: 777, 2014 Sep 09.
Article in English | MEDLINE | ID: mdl-25204312

ABSTRACT

BACKGROUND: MicroRNAs (miRNAs) play a pivotal role in coordinating messenger RNA (mRNA) transcription and stability in almost all known biological processes, including the development of the central nervous system. Despite our broad understanding of their involvement, we still have a very sparse understanding of specifically how miRNA contribute to the strict regional and temporal regulation of brain development. Accordingly, in the current study we have examined the contribution of miRNA in the developing rat telencephalon and mesencephalon from just after neural tube closure till birth using a genome-wide microarray strategy. RESULTS: We identified temporally distinct expression patterns in both the telencephalon and mesencephalon for both miRNAs and their target genes. We demonstrate direct miRNA targeting of several genes involved with the migration, differentiation and maturation of neurons. CONCLUSIONS: Our findings suggest that miRNA have significant implications for the development of neural structure and support important mechanisms that if disrupted, may contribute to or drive neurodevelopmental disorders.


Subject(s)
Brain/embryology , Brain/metabolism , Gene Expression Regulation, Developmental , MicroRNAs/genetics , Organogenesis/genetics , Animals , Animals, Newborn , Cell Line , Cluster Analysis , Gene Expression , Gene Expression Profiling , Gene Regulatory Networks , Gene Silencing , Genes, Reporter , Humans , Mesencephalon/embryology , Mesencephalon/metabolism , RNA Interference , RNA, Messenger/genetics , Rats , Signal Transduction , Telencephalon/embryology , Telencephalon/metabolism
4.
Brain Behav Immun Health ; 3: 100048, 2020 Mar.
Article in English | MEDLINE | ID: mdl-34589838

ABSTRACT

BACKGROUND: Although the aetiology of schizophrenia remains unknown, it has been suggested that it might occur in response to alterations in the gut-brain axis (GBA), the bi-directional communication system between the gut and the brain. The current study aimed to determine whether the "two-hit" animal model of neuropsychopathology (maternal immune activation combined with adolescent cannabinoid exposure), produced abnormalities in the GBA. METHOD: Pregnant Wistar rats were administered the viral mimetic polyI:C on gestational day 19 and offspring were administered the synthetic cannabinoid HU210 from postnatal days 35-48. Evidence of GBA activation was assessed in the hypothalamus, colon and fecal samples from male and female offspring at adolescence and adulthood. RESULTS: Findings were sex-specific with adolescent female offspring exhibiting an increased hypothalamic inflammatory profile, increased hypothalamic CRHR1 mRNA, and decreased fecal expression of Bifidobacterium longum, however, no changes were detected in colonic inflammation or integrity. CONCLUSION: These results indicate that the rat two-hit model, documented to produce behavioural and neuroanatomical abnormalities, also produces hypothalamic and microbiota abnormalities. The results also demonstrate significant sex differences, suggesting that this model may be useful for investigating the role of the GBA in the aetiology of neurodevelopmental disorders such as schizophrenia.

5.
Prog Neurobiol ; 143: 61-81, 2016 08.
Article in English | MEDLINE | ID: mdl-27317386

ABSTRACT

The developmental processes that establish the synaptic architecture of the brain while retaining capacity for activity-dependent remodeling, are complex and involve a combination of genetic and epigenetic influences. Dysregulation of these processes can lead to problems with neural circuitry which manifest in humans as a range of neurodevelopmental syndromes, such as schizophrenia, bipolar disorder and fragile X mental retardation. Recent studies suggest that prenatal, postnatal and intergenerational environmental factors play an important role in the aetiology of stress-related psychopathology. A number of these disorders have been shown to display epigenetic changes in the postmortem brain that reflect early life experience. These changes affect the regulation of gene expression though chromatin remodeling (transcriptional) and post-transcriptional influences, especially small noncoding microRNA (miRNA). These dynamic and influential molecules appear to play an important function in both brain development and its adaption to stress. In this review, we examine the role of miRNA in mediating the brain's response to both prenatal and postnatal environmental perturbations and explore how stress- induced alterations in miRNA expression can regulate the stress response via modulation of the immune system. Given the close relationship between environmental stress, miRNA, and brain development/function, we assert that miRNA hold a significant position at the molecular crossroads between neural development and adaptations to environmental stress. A greater understanding of the dynamics that mediate an individual's predisposition to stress-induced neuropathology has major human health benefits and is an important area of research.


Subject(s)
Brain/metabolism , MicroRNAs/metabolism , Stress, Physiological/physiology , Stress, Psychological/metabolism , Animals , Humans
SELECTION OF CITATIONS
SEARCH DETAIL